C14H7Cl2NO3
308.1 g/mol
APIDanger
Vyndamax
CAS594839-88-0EC813-715-5
Category
API
Compound Class
Organic Acid
Primary Use
Pharmaceutical Raw Material
Tafamidis is a benzoxazole derivative used as an active pharmaceutical ingredient. It is a monocarboxylic acid and a member of the 1,3-benzoxazoles class, developed for applications related to transthyretin-mediated amyloidosis.
pharmaceutical raw material for transthyretin amyloidosis formulationsactive ingredient in research for polyneuropathy associated with transthyretin amyloidosis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 594839-88-0
Related Compounds
ReferenceSame Category
Megestrol acetate
CAS595-33-5
pharmaceutical raw material
ReferenceSame Category
Algestone
CAS595-77-7
pharmaceutical raw material
ReferenceSame Category
Berberine chloride dihydrate
CAS5956-60-5
pharmaceutical raw material
ReferenceSame Category
Sodium oxolinate
CAS59587-08-5
pharmaceutical raw material
Referencesame scaffold
5-Bromo-2-phenyl-1,3-benzoxazole
CAS69918-19-0
pharmaceutical intermediate
Referencesame scaffold
4-bromo-2-phenylbenzo[d]oxazole
CAS1792993-81-7
research compound
Referencesame scaffold
STK360416
CAS397-54-6
research compound
Safety Reference
Danger
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H360May damage fertility or the unborn child
H362May cause harm to breast-fed children
Identifiers
IUPAC Name
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
InChIKey
TXEIIPDJKFWEEC-UHFFFAOYSA-N
SMILES
C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
Synonyms (18)
- 3MI
- Tafamidis (JAN/USAN/INN)
- 4his
- 594839-88-0 (free acid)
- Fx 1006
- PF-06291826(Tafamidis)
- TAFAMIDIS [MART.]
- Tafamidis
- Vyndamax
- Vyndamax (TN)
- Vynmac (TN)
- tafamidis-meglumine
- tafamidisum